Mounjaro vs Ozempic for Weight Loss: Which One Wins?

If you’ve spent any time researching GLP-1 medications, you’ve probably stumbled across two names more than any others: Mounjaro (tirzepatide) and Ozempic (semaglutide). Both are injectable medications originally approved for type 2 diabetes that have taken the weight loss world by storm — but they work differently, cost differently, and deliver different results. So which one actually wins?

Let’s break it down honestly.

How They Work: Same Family, Different Mechanisms

Both medications belong to the GLP-1 (glucagon-like peptide-1) receptor agonist class, but here’s the key difference:

• Ozempic (semaglutide) activates only GLP-1 receptors. It slows digestion, reduces appetite, and lowers blood sugar.
• Mounjaro (tirzepatide) activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual-action mechanism gives it a stronger metabolic effect.

Think of it like this: Ozempic uses one lever to slow your appetite engine; Mounjaro uses two. That difference shows up significantly in the clinical data.

Clinical Trial Results: The Numbers Don’t Lie

Ozempic / Wegovy (Semaglutide)

In the STEP 1 trial — the landmark study for Wegovy (the weight-loss-approved version of semaglutide at 2.4mg weekly) — participants lost an average of 14.9% of their body weight over 68 weeks. For a 200-pound person, that’s roughly 30 pounds.

Mounjaro / Zepbound (Tirzepatide)

In the SURMOUNT-1 trial for Zepbound (the weight-loss-approved version of tirzepatide), participants on the highest dose lost an average of 20.9% of their body weight — nearly a quarter of their starting weight. That same 200-pound person? Down roughly 42 pounds.

Head-to-head, tirzepatide consistently outperforms semaglutide in weight loss. A 2023 study published in JAMA Internal Medicine confirmed this in real-world data — tirzepatide users lost significantly more weight across all time points.

Side Effects: What to Expect

Both medications share a similar side effect profile, since they both activate GLP-1 receptors:

• Nausea (most common, especially early on)
• Vomiting
• Diarrhea or constipation
• Fatigue
• Reduced appetite (this one is kind of the point)

In trials, both drugs had comparable rates of GI side effects, though some people report Mounjaro causes more nausea at higher doses. The good news: most side effects improve after the first few weeks as your body adjusts.

Both carry a black box warning for thyroid C-cell tumors (based on animal studies), and neither should be used if you have a personal or family history of medullary thyroid carcinoma or MEN2.

Cost and Insurance: The Painful Part

Ozempic

List price: ~$935/month. With insurance for diabetes, often covered. For weight loss only (Wegovy), coverage is spottier — but improving as more employers add it.

Mounjaro / Zepbound

List price: ~$1,060/month. Eli Lilly offers a savings card that can bring it to $550/month or less for commercially insured patients. Zepbound (the weight-loss version) has been expanding insurance coverage quickly.

Compounded versions of both drugs exist through telehealth platforms at significantly lower prices ($200–$400/month) — though the FDA has been tightening rules around compounded semaglutide and tirzepatide as shortages ease.

Availability

Both drugs have faced shortage issues, though supply has stabilized considerably in 2025–2026. Zepbound tends to be slightly easier to find than Wegovy at the moment, but availability varies by pharmacy and region.

So, Which One Wins?

If you’re purely looking at weight loss results, Mounjaro/Zepbound (tirzepatide) wins on efficacy. The clinical data is clear: it produces greater average weight loss across all doses.

But Ozempic/Wegovy isn’t out of the picture. It has a longer track record, more published safety data, and may be better tolerated for some people. It’s also the first choice many doctors reach for.

The honest answer? The best medication is the one your doctor recommends for your health profile, that your insurance covers (or you can afford), and that you can actually get your hands on consistently.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications require a prescription and should only be used under the supervision of a qualified healthcare provider. Results vary by individual. Always consult your doctor before starting, stopping, or changing any medication or weight loss program.